|
1
|
Solnica B, Sygitowicz G, Sitkiewicz D,
Cybulska B, Jóźwiak J, Odrowąż-Sypniewska G and Banach M: 2020
Guidelines of the Polish Society of Laboratory Diagnostics (PSLD)
and the Polish Lipid Association (PoLA) on laboratory diagnostics
of lipid metabolism disorders. Arch Med Sci. 16:237–252.
2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zhu JR, Gao RL, Zhao SP, Lu GP, Zhao D and
Li JJ: 2016 Chinese guidelines for the management of dyslipidemia
in adults. J Geriat Cardiol. 15:1–29. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Lim SY, Steiner JM and Cridge H: Lipases:
It's not just pancreatic lipase! Am J Veterinary. Res. 83:348–358.
2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Gilbert M: Role of skeletal muscle lipids
in the pathogenesis of insulin resistance of obesity and type 2
diabetes. J Diabetes Investig. 12:1934–1941. 2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Yan Y, Wang D, Sun Y, Ma Q, Wang K, Liao
Y, Chen C, Jia H, Chu C, Zheng W, et al: Triglyceride-glucose index
trajectory and arterial stiffness: Results from Hanzhong Adolescent
Hypertension Cohort Study. Cardiovasc Diabetol.
21(33)2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Williams PT: Gene-environment interactions
due to quantile-specific heritability of triglyceride and VLDL
concentrations. Sci Rep. 10(4486)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Dron JS, Wang J, McIntyre AD, Iacocca MA,
Robinson JF, Ban MR, Cao H and Hegele RA: Six years' experience
with LipidSeq: Clinical and research learnings from a hybrid,
targeted sequencing panel for dyslipidemias. BMC Med Genomics.
13(23)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Petrie JR, Guzik TJ and Touyz RM:
Diabetes, hypertension, and cardiovascular disease: Clinical
insights and vascular mechanisms. Can J Cardiol. 34:575–584.
2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Beisiegel U: Lipoprotein metabolism. Eur
Heart J. 19 (Suppl A):A20–A23. 1998.PubMed/NCBI
|
|
10
|
Xie C, Wang ZC, Liu XF and Yang MS: The
common biological basis for common complex diseases: Evidence from
lipoprotein lipase gene. Eur J Hum Genet. 18:3–7. 2010.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Olefsky JM and Glass CK: Macrophages,
inflammation, and insulin resistance. Ann Rev Physiol. 72:219–246.
2010.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Rosmond R, Ukkola O, Chagnon M, Bouchard C
and Björntorp P: Polymorphisms of the beta2-adrenergic receptor
gene (ADRB2) in relation to cardiovascular risk factors in men. J
Intern Med. 248:239–244. 2000.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Willer CJ, Schmidt EM, Sengupta S, Peloso
GM, Gustafsson S, Kanoni S, Ganna A, Chen J, Buchkovich ML, Mora S,
et al: Discovery and refinement of loci associated with lipid
levels. Nat Genet. 45:1274–1283. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Teslovich TM, Musunuru K, Smith AV,
Edmondson AC, Stylianou IM, Koseki M, Pirruccello JP, Ripatti S,
Chasman DI, Willer CJ, et al: Biological, clinical and population
relevance of 95 loci for blood lipids. Nature. 466:707–713.
2010.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tan PY and Mitra SR: The combined effect
of polygenic risk from FTO and ADRB2 Gene variants, odds of
obesity, and post-hipcref diet differences. Lifestyle Genomics.
13:84–98. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Sikhayeva N, Talzhanov Y, Iskakova A,
Dzharmukhanov J, Nugmanova R, Zholdybaeva E and Ramanculov E: Type
2 diabetes mellitus: Distribution of genetic markers in Kazakh
population. Clin Interv Aging. 13:377–388. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Shakhanova A, Aukenov N, Nurtazina A,
Massabayeva M, Babenko D, Adiyeva M and Shaimardonov N: Association
of polymorphism genes LPL, ADRB2, AGT and AGTR1 with risk of
hyperinsulinism and insulin resistance in the Kazakh population.
Biomed Rep. 13(35)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
1000 Genomes Project Consortium. Auton A,
Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL,
McCarthy S, McVean GA and Abecasis GR: A global reference for human
genetic variation. Nature. 526:68–74. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Dai HJ, Wu JCY, Tsai RTH, Pan WH and Hsu
WL: T-HOD: A literature-based candidate gene database for
hypertension, obesity and diabetes. Database (Oxford.
2013(bas061)2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Bastien M, Poirier P, Lemieux I and
Després JP: Overview of epidemiology and contribution of obesity to
cardiovascular disease. Prog Cardiovasc Dis. 56:369–381.
2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Mach F, Baigent C, Catapano AL, Koskinas
KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V,
Ference BA, et al: 2019 ESC/EAS Guidelines for the management of
dyslipidaemias: Lipid modification to reduce cardiovascular risk.
Eur Heart J. 41:111–188. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ference BA, Kastelein JJP, Ray KK,
Ginsberg HN, Chapman MJ, Packard CJ, Laufs U, Oliver-Williams C,
Wood AM, Butterworth AS, et al: Association of
triglyceride-lowering LPL variants and LDL-C-lowering LDLR variants
with risk of coronary heart disease. JAMA. 321:364–373.
2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Lechner K, McKenzie AL, Kränkel N, Von
Schacky C, Worm N, Nixdorff U, Lechner B, Scherr J, Weingärtner O
and Krauss RM: High-risk atherosclerosis and metabolic phenotype:
The roles of ectopic adiposity, atherogenic dyslipidemia, and
inflammation. Metab Syndr Relat Disord. 18:176–185. 2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Patwardhan V, Khadilkar A, Chiplonkar S
and Khadilkar V: Dyslipidemia and Fat Distribution in Normal Weight
Insulin Resistant Men. J Assoc Physicians India. 67:26–29.
2019.PubMed/NCBI
|
|
26
|
Liu A, Lee L, Zhan S, Cao W, Lv J, Guo X
and Hu Y: The S447X polymorphism of the lipoprotein lipase gene is
associated with lipoprotein lipid and blood pressure levels in
Chinese patients with essential hypertension. J Hypertens.
22:1503–1509. 2004.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Chen P, Jou YS, Fann CS, Chen JW, Chung
CM, Lin CY, Wu SY, Kang MJ, Chen YC, Jong YS, et al: Lipoprotein
lipase variants associated with an endophenotype of hypertension:
Hypertension combined with elevated triglycerides. Hum Mutat.
30:49–55. 2009.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Matsunaga A, Nagashima M, Yamagishi H and
Saku K: Variants of Lipid-related genes in adult japanese patients
with severe hypertriglyceridemia. J Atheroscler Thromb.
27:1264–1277. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Gonzalez Sanchez JL, Proenza AM, Martinez
Larrad MT, Ramis JM, Fernandez Perez C, Palou A and Serrano Ríos M:
The glutamine 27 glutamic acid polymorphism of the
beta2-adrenoceptor gene is associated with abdominal obesity and
greater risk of impaired glucose tolerance in men but not in women:
A population-based study in Spain. Clin Endocrinol (Oxf).
59:476–481. 2003.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Apalasamy YD, Ming MF, Rampal S, Bulgiba A
and Mohamed Z: Gender-dependent association of a β(2)-adrenergic
gene variant with obesity parameters in malaysian malays. Asia Pac
J Public Health. 27:NP154–NP165. 2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
El-Menyar A, Rizk NM, Asim M, Al-Thani H,
Elgendy A and Al-Suwaidi J: Association of β-adrenergic receptor
gene polymorphisms with acute coronary syndrome and cardiovascular
risk factors in an arab population. Angiology. 67:762–771.
2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Lee S, Kim CM, Kim HJ and Park HS:
Interactive effects of main genotype, caloric intakes, and smoking
status on risk of obesity. Asia Pac J Clin Nutr. 20:563–571.
2011.PubMed/NCBI
|
|
33
|
Wang Y, Zhang J, Ma Y, Song X, Li S, Zhan
X and Wu L: Different lipid profiles, insulin sensitivity, and
insulin resistance among Han, Uygur, and Kazak men with normal
glucose tolerance in Xinjiang, China. Lipids Health Dis.
17(209)2018.PubMed/NCBI View Article : Google Scholar
|
